Onconetix Inc (ONCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,215 | -14,032 | -19,702 | -10,918 | -8,546 |
| Depreciation Amortization | 5 | 139 | 132 | 13 | 10 |
| Accounts receivable | 321 | -319 | 25 | 16 | 10 |
| Accounts payable and accrued liabilities | -225 | -1,094 | -1,048 | -273 | -261 |
| Other Working Capital | -38 | -2,420 | -1,314 | -139 | -70 |
| Other Operating Activity | 2,030 | 8,047 | 15,319 | 7,891 | 6,858 |
| Operating Cash Flow | $-2,122 | $-9,678 | $-6,588 | $-3,410 | $-2,000 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 247 | 1,336 | 875 | 475 | 100 |
| Common Stock Issued | 385 | N/A | 6,392 | 6,392 | 5,027 |
| Common Stock Repurchased | N/A | 6,392 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 6,725 | 639 | -3,252 | -2,256 |
| Financing Cash Flow | $632 | $14,453 | $7,906 | $3,615 | $2,870 |
| Exchange Rate Effect | -15 | -200 | -1,128 | -568 | 60 |
| Beginning Cash Position | 5,221 | 647 | 647 | 647 | 647 |
| End Cash Position | 3,716 | 5,221 | 837 | 284 | 1,577 |
| Net Cash Flow | $-1,505 | $4,574 | $190 | $-363 | $931 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,122 | -9,678 | -6,588 | -3,410 | -2,000 |
| Free Cash Flow | -2,122 | -9,678 | -6,588 | -3,410 | -2,000 |